CRCronos Group Inc. CRON · NASDAQ
$3.30 -1.79% (-$0.06)
- Market cap
- $1.24B
- Enterprise value
- $772.1M
- P/E
- 17.7x
- Forward P/E
- 19.1x
- PEG
- -
- P/S
- 5.1x
- P/FCF
- 27.8x
- EV/EBITDA
- 31.7x
- ROIC
- 1.3%
- Gross margin
- 33.5%
- Net margin
- 28.7%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -19.1x
- Beta
- 1.20
- Free float
- 50.8%
About the company
Cronos Group Inc. (CRON) is a Canadian company operating in the legal cannabis industry and cannabis-based products. The company specializes in cultivating and producing cannabis for medical and recreational purposes. Cronos Group has a global presence and operates in several countries where cannabis and its products are legal. The company offers a wide range of products, including dried cannabis, oils, tinctures, vaporizer cartridges, and other consumer products based on cannabis. Cronos Group Inc. closely monitors regulations and laws related to legal cannabis in various countries and strives to maintain the highest standards of quality and safety for its products. Shares of Cronos Group Inc. (CRON) can present an interesting investment opportunity for investors following the growing market of legal cannabis and its products.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Michael Ryan Gorenstein
Employees
610
Headquarters
Stayner
Valuation
Is today's price reasonable?
- What to watch: The share price is above the Bulios Fair Price.
Growth and estimates
Is it growing, and what comes next?
- What speaks for it: Revenue grew by 31% a year over the last 3 years.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What speaks for it: Out of every 100 USD of revenue, 29 USD is left as net profit.
- What to watch: It earns only 1.3 USD a year on every 100 USD of invested capital.
Financial health
Can it carry its debt?
- What speaks for it: It holds more cash than debt: $467.0M against $1.30M.
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number